Veradermics, Inc.
Regulated industryPhysical productsDevelopment stageTags from an AI model reading the company description.
Key Metrics
- Previous Close
- $125.64
- 52-Week Range
- $32.00 – $156.63
- Market Cap
- $5.27B
- P/E (TTM)
- —
- EPS (TTM)
- -3.89
- Dividend Yield
- 0.00%
Advanced Metrics
- Price/Book
- 6.61
- PEG Ratio
- —
- Return on Equity
- -23.12%
- Return on Assets
- -16.83%
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Profit Margin
- 0.00%
- Current Ratio
- 77.68
- Debt/Equity
- 0.00
- Total Debt
- $371.00K
- Free Cash Flow
- $-55.22M
- Revenue Growth
- —
- Earnings Growth
- —
- Enterprise Value
- $4.47B
Market Snapshot
About
Veradermics, Inc. is a dermatology therapeutics company focused on developing treatments for skin conditions. The company works on novel pharmaceutical solutions for dermatological disorders. Veradermics aims to address unmet needs in the dermatology market.